Skip to main content

Table 1 Symptoms developed in patients after 12 weeks of treatment

From: Sofosbuvir/ledipasvir safety and efficacy for HCV patients with haemodialysis and liver cirrhosis: a small retrospective study

Characteristic Negative Positive
HCV 1a (n=10)
 Lethargy 6 2
 Headache 8 0
 Nausea 4 4
 Diarrhoea 6 2
 Dizziness 6 2
 Shortness of breath 7 1
 Insomnia 5 3
 Arthralgia 4 4
 Mood disturbances 4 4
HCV 1b (n=2)
 Lethargy 1 1
 Headache 1 1
 Nausea 1 1
 Diarrhoea 0 2
 Dizziness 2 0
 Shortness of breath 2 0
 Insomnia 2 0
 Arthralgia 1 1
 Mood disturbances 2 0
HCV 4 (n=8)
 Lethargy 5 1
 Headache 6 0
 Nausea 4 2
 Diarrhoea 5 1
 Dizziness 4 2
 Shortness of breath 6 0
 Insomnia 4 2
 Arthralgia 3 3
 Mood disturbances 4 2
HCV 5 (n=1)
 Lethargy 1 0
 Headache 1 0
 Nausea 1 0
 Diarrhoea 1 0
 Dizziness 1 0
 Shortness of breath 1 0
 Insomnia 1 0
 Arthralgia 1 0
 Mood disturbances 1 0